691 related articles for article (PubMed ID: 28216244)
21. Protective efficacy and safety of radiation-attenuated and chemo-attenuated Plasmodium Falciparum sporozoite vaccines against controlled and natural malaria infection: a systematic review and meta-analysis of randomized controlled trials.
Abuelazm MT; Elzeftawy MA; Kamal MA; Badr H; Gamal M; Aboulgheit M; Abdelazeem B; Abd-Elsalam S; Abouzid M
Infection; 2024 Jun; 52(3):707-722. PubMed ID: 38319556
[TBL] [Abstract][Full Text] [Related]
22. Intermittent preventive therapy for malaria with monthly artemether-lumefantrine for the post-discharge management of severe anaemia in children aged 4-59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial.
Phiri K; Esan M; van Hensbroek MB; Khairallah C; Faragher B; ter Kuile FO
Lancet Infect Dis; 2012 Mar; 12(3):191-200. PubMed ID: 22172305
[TBL] [Abstract][Full Text] [Related]
23. Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean Men.
Olotu A; Urbano V; Hamad A; Eka M; Chemba M; Nyakarungu E; Raso J; Eburi E; Mandumbi DO; Hergott D; Maas CD; Ayekaba MO; Milang DN; Rivas MR; Schindler T; Embon OM; Ruben AJ; Saverino E; Abebe Y; Kc N; James ER; Murshedkar T; Manoj A; Chakravarty S; Li M; Adams M; Schwabe C; Segura JL; Daubenberger C; Tanner M; Richie TL; Billingsley PF; Lee Sim BK; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2018 Jan; 98(1):308-318. PubMed ID: 29141739
[TBL] [Abstract][Full Text] [Related]
24. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
Sirima SB; Richert L; Chêne A; Konate AT; Campion C; Dechavanne S; Semblat JP; Benhamouda N; Bahuaud M; Loulergue P; Ouédraogo A; Nébié I; Kabore M; Kargougou D; Barry A; Ouattara SM; Boilet V; Allais F; Roguet G; Havelange N; Lopez-Perez E; Kuppers A; Konaté E; Roussillon C; Kanté M; Belarbi L; Diarra A; Henry N; Soulama I; Ouédraogo A; Esperou H; Leroy O; Batteux F; Tartour E; Viebig NK; Thiebaut R; Launay O; Gamain B
Lancet Infect Dis; 2020 May; 20(5):585-597. PubMed ID: 32032566
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine for the treatment of acute uncomplicated malaria in pregnancy.
Ukah M; Badejoko O; Ogunniyi S; Loto O; Aboderin O; Fatusi A
Int J Gynaecol Obstet; 2015 Oct; 131(1):41-4. PubMed ID: 26169336
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
Piola P; Nabasumba C; Turyakira E; Dhorda M; Lindegardh N; Nyehangane D; Snounou G; Ashley EA; McGready R; Nosten F; Guerin PJ
Lancet Infect Dis; 2010 Nov; 10(11):762-9. PubMed ID: 20932805
[TBL] [Abstract][Full Text] [Related]
27. Comparative evaluation of efficacy and safety of artesunate-lumefantrine vs. artemether-lumefantrine fixed-dose combination in the treatment of uncomplicated Plasmodium falciparum malaria.
Pareek A; Chandurkar N; Srivastav V; Lakhani J; Karmakar PS; Basu S; Ray A; Pednekar S; Gupta PB; Suthar N; Lakhani S
Trop Med Int Health; 2013 May; 18(5):578-87. PubMed ID: 23489465
[TBL] [Abstract][Full Text] [Related]
28. Immunogenicity and Protective Efficacy of Radiation-Attenuated and Chemo-Attenuated PfSPZ Vaccines in Equatoguinean Adults.
Jongo SA; Urbano V; Church LWP; Olotu A; Manock SR; Schindler T; Mtoro A; Kc N; Hamad A; Nyakarungu E; Mpina M; Deal A; Bijeri JR; Ondo Mangue ME; Ntutumu Pasialo BE; Nguema GN; Owono SN; Rivas MR; Chemba M; Kassim KR; James ER; Stabler TC; Abebe Y; Saverino E; Sax J; Hosch S; Tumbo AM; Gondwe L; Segura JL; Falla CC; Phiri WP; Hergott DEB; García GA; Schwabe C; Maas CD; Murshedkar T; Billingsley PF; Tanner M; Ayekaba MO; Sim BKL; Daubenberger C; Richie TL; Abdulla S; Hoffman SL
Am J Trop Med Hyg; 2021 Jan; 104(1):283-293. PubMed ID: 33205741
[No Abstract] [Full Text] [Related]
29. A clinical and pharmacokinetic trial of six doses of artemether-lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand.
Lefèvre G; Looareesuwan S; Treeprasertsuk S; Krudsood S; Silachamroon U; Gathmann I; Mull R; Bakshi R
Am J Trop Med Hyg; 2001; 64(5-6):247-56. PubMed ID: 11463111
[TBL] [Abstract][Full Text] [Related]
30. Use of ChAd3-EBO-Z Ebola virus vaccine in Malian and US adults, and boosting of Malian adults with MVA-BN-Filo: a phase 1, single-blind, randomised trial, a phase 1b, open-label and double-blind, dose-escalation trial, and a nested, randomised, double-blind, placebo-controlled trial.
Tapia MD; Sow SO; Lyke KE; Haidara FC; Diallo F; Doumbia M; Traore A; Coulibaly F; Kodio M; Onwuchekwa U; Sztein MB; Wahid R; Campbell JD; Kieny MP; Moorthy V; Imoukhuede EB; Rampling T; Roman F; De Ryck I; Bellamy AR; Dally L; Mbaya OT; Ploquin A; Zhou Y; Stanley DA; Bailer R; Koup RA; Roederer M; Ledgerwood J; Hill AVS; Ballou WR; Sullivan N; Graham B; Levine MM
Lancet Infect Dis; 2016 Jan; 16(1):31-42. PubMed ID: 26546548
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and safety of re-treatment with the same artemisinin-based combination treatment (ACT) compared with an alternative ACT and quinine plus clindamycin after failure of first-line recommended ACT (QUINACT): a bicentre, open-label, phase 3, randomised controlled trial.
Mavoko HM; Nabasumba C; da Luz RI; Tinto H; D'Alessandro U; Kambugu A; Baraka V; Rosanas-Urgell A; Lutumba P; Van Geertruyden JP
Lancet Glob Health; 2017 Jan; 5(1):e60-e68. PubMed ID: 27840069
[TBL] [Abstract][Full Text] [Related]
32. Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali.
Kayentao K; Ongoiba A; Preston AC; Healy SA; Doumbo S; Doumtabe D; Traore A; Traore H; Djiguiba A; Li S; Peterson ME; Telscher S; Idris AH; Kisalu NK; Carlton K; Serebryannyy L; Narpala S; McDermott AB; Gaudinski M; Traore S; Cisse H; Keita M; Skinner J; Hu Z; Zéguimé A; Ouattara A; Doucoure M; Dolo A; Djimdé A; Traore B; Seder RA; Crompton PD;
N Engl J Med; 2022 Nov; 387(20):1833-1842. PubMed ID: 36317783
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
Groome MJ; Fairlie L; Morrison J; Fix A; Koen A; Masenya M; Jose L; Madhi SA; Page N; McNeal M; Dally L; Cho I; Power M; Flores J; Cryz S
Lancet Infect Dis; 2020 Jul; 20(7):851-863. PubMed ID: 32251641
[TBL] [Abstract][Full Text] [Related]
34. Single low dose primaquine to reduce gametocyte carriage and Plasmodium falciparum transmission after artemether-lumefantrine in children with asymptomatic infection: a randomised, double-blind, placebo-controlled trial.
Gonçalves BP; Tiono AB; Ouédraogo A; Guelbéogo WM; Bradley J; Nebie I; Siaka D; Lanke K; Eziefula AC; Diarra A; Pett H; Bougouma EC; Sirima SB; Drakeley C; Bousema T
BMC Med; 2016 Mar; 14():40. PubMed ID: 26952094
[TBL] [Abstract][Full Text] [Related]
35. Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study.
Held J; Supan C; Salazar CL; Tinto H; Bonkian LN; Nahum A; Moulero B; Sié A; Coulibaly B; Sirima SB; Siribie M; Otsyula N; Otieno L; Abdallah AM; Kimutai R; Bouyou-Akotet M; Kombila M; Koiwai K; Cantalloube C; Din-Bell C; Djeriou E; Waitumbi J; Mordmüller B; Ter-Minassian D; Lell B; Kremsner PG
Lancet Infect Dis; 2015 Dec; 15(12):1409-19. PubMed ID: 26342427
[TBL] [Abstract][Full Text] [Related]
36. Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian Adults.
Jongo SA; Church LWP; Mtoro AT; Schindler T; Chakravarty S; Ruben AJ; Swanson PA; Kassim KR; Mpina M; Tumbo AM; Milando FA; Qassim M; Juma OA; Bakari BM; Simon B; James ER; Abebe Y; Kc N; Saverino E; Fink M; Cosi G; Gondwe L; Studer F; Styers D; Seder RA; Schindler T; Billingsley PF; Daubenberger C; Sim BKL; Tanner M; Richie TL; Abdulla S; Hoffman SL
Clin Infect Dis; 2020 Dec; 71(11):2849-2857. PubMed ID: 31782768
[TBL] [Abstract][Full Text] [Related]
37. Comparison of shortened mosaic HIV-1 vaccine schedules: a randomised, double-blind, placebo-controlled phase 1 trial (IPCAVD010/HPX1002) and a preclinical study in rhesus monkeys (NHP 17-22).
Stephenson KE; Wegmann F; Tomaka F; Walsh SR; Tan CS; Lavreys L; Ansel JL; Kanjilal DG; Jaegle K; Nkolola JP; Peter L; Fogel R; Bradshaw C; Tyler A; Makoni T; Howe L; Quijada D; Chandrashekar A; Bondzie EA; Borducchi EN; Yanosick KE; Hendriks J; Nijs S; Truyers C; Tolboom J; Zahn RC; Seaman MS; Alter G; Stieh DJ; Pau MG; Schuitemaker H; Barouch DH
Lancet HIV; 2020 Jun; 7(6):e410-e421. PubMed ID: 32078815
[TBL] [Abstract][Full Text] [Related]
38. Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial.
Sulyok Z; Fendel R; Eder B; Lorenz FR; Kc N; Karnahl M; Lalremruata A; Nguyen TT; Held J; Adjadi FAC; Klockenbring T; Flügge J; Woldearegai TG; Lamsfus Calle C; Ibáñez J; Rodi M; Egger-Adam D; Kreidenweiss A; Köhler C; Esen M; Sulyok M; Manoj A; Richie TL; Sim BKL; Hoffman SL; Mordmüller B; Kremsner PG
Nat Commun; 2021 May; 12(1):2518. PubMed ID: 33947856
[TBL] [Abstract][Full Text] [Related]
39. Protection against
Epstein JE; Paolino KM; Richie TL; Sedegah M; Singer A; Ruben AJ; Chakravarty S; Stafford A; Ruck RC; Eappen AG; Li T; Billingsley PF; Manoj A; Silva JC; Moser K; Nielsen R; Tosh D; Cicatelli S; Ganeshan H; Case J; Padilla D; Davidson S; Garver L; Saverino E; Murshedkar T; Gunasekera A; Twomey PS; Reyes S; Moon JE; James ER; Kc N; Li M; Abot E; Belmonte A; Hauns K; Belmonte M; Huang J; Vasquez C; Remich S; Carrington M; Abebe Y; Tillman A; Hickey B; Regules J; Villasante E; Sim BKL; Hoffman SL
JCI Insight; 2017 Jan; 2(1):e89154. PubMed ID: 28097230
[No Abstract] [Full Text] [Related]
40. A Phase II Pilot Trial to Evaluate
Noudjiegbe AN; Alikekere FN; Tchehouenou H; Langa Y; Ota DS; Degbelo JE; Allabi ACE
Evid Based Complement Alternat Med; 2020; 2020():8715021. PubMed ID: 32215047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]